Latest filingAug 19, 2026Most recent Form 4
TECH
BIO-TECHNE Corp
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/10 to 09/10. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$06 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period48transactions
- M · Option exercise · dominant22 · 46%
- A · Grants / awards11 · 23%
- D · Issuer dispositions10 · 21%
- F · Tax withholding5 · 10%
Activity by reported role
A joint filing can contribute to multiple roles59transactions
- Chief executive officer · dominant12 · 20%
- PRES11 · 19%
- GC10 · 17%
- Chief financial officer9 · 15%
- PS9 · 15%
- Director6 · 10%
- SB2 · 3%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (6)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeBohnen ShaneRestricted Stock Units · Direct
18,432Aug 17, 2026
Herr Amy E.Restricted Stock Units · Indirect · By significant other
1,381Aug 17, 2026
Geist WilliamRestricted Stock Units · Direct
14,762Aug 17, 2026
Hippel JamesRestricted Stock Units · Direct
22,438Aug 17, 2026
Kelderman KimRestricted Stock Units · Direct
93,582Aug 17, 2026
Kelderman KimPerformance Restricted Stock Units · Direct
8,319Aug 15, 2026
Herr Amy E.Common Stock · Indirect · By significant other
789Aug 15, 2026
Bohnen ShaneCommon Stock · Direct
10,360Aug 15, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 10 → Sep 10
LessMore
Top insiders
By absolute net value across the selected period- KK-$783.4k
- HJ-$312.0k
- GW-$143.1k
- BS-$97.2k
- HE-$15.4k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
TECH transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| TECH | Bohnen Shane | GC | grant | 18.4k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Bohnen Shane | GC | grant | 11.3k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Kelderman Kim | CEO | grant | 93.5k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Kelderman Kim | CEO | grant | 57.5k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Hippel James | CFO | grant | 36.4k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Hippel James | CFO | grant | 22.4k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Herr Amy E. | DIR | grant | 1.38k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Geist William | PRESPS | grant | 23.9k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Geist William | PRESPS | grant | 14.7k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Crouse Steven C. | PRESSB | grant | 14.1k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Crouse Steven C. | PRESSB | grant | 8.70k | $0 | A | −0.4% | 08/19 | 08/17 | |
| TECH | Kelderman Kim | CEO | exercise | 11.7k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | exercise | 8.54k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | return | 24.3k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | return | 8.83k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | exercise | 588 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | return | 22.3k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | return | 8.31k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | exercise | 554 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | withholding | 10.8k | -$78.3M | F | −0.1% | 08/18 | 08/15 | |
| TECH | Kelderman Kim | CEO | exercise | 21.4k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | exercise | 4.90k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | exercise | 4.01k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | return | 34.9k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | return | 12.9k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | exercise | 866 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | withholding | 4.30k | -$31.2M | F | −0.1% | 08/18 | 08/15 | |
| TECH | Hippel James | CFO | exercise | 9.77k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | exercise | 3.22k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | exercise | 2.62k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | return | 22.8k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | return | 8.50k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | exercise | 567 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | withholding | 1.97k | -$14.3M | F | −0.1% | 08/18 | 08/15 | |
| TECH | Geist William | PRESPS | exercise | 6.41k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | exercise | 2.33k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | exercise | 1.66k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | return | 4.50k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | exercise | 300 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | return | 12.1k | $0 | D | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | exercise | 49 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | withholding | 1.34k | -$9.72M | F | −0.1% | 08/18 | 08/15 | |
| TECH | Bohnen Shane | GC | exercise | 4.34k | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Herr Amy E. | DIR | exercise | 311 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Herr Amy E. | DIR | exercise | 160 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Herr Amy E. | DIR | exercise | 118 | $0 | M | −0.1% | 08/18 | 08/15 | |
| TECH | Herr Amy E. | DIR | withholding | 213 | -$1.54M | F | −0.1% | 08/18 | 08/15 | |
| TECH | Herr Amy E. | DIR | exercise | 589 | $0 | M | −0.1% | 08/18 | 08/15 |
BIO-TECHNE Corp Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at BIO-TECHNE Corp?
Bohnen Shane, Kelderman Kim, Hippel James, Herr Amy E., Geist William, Crouse Steven C..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.